Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mild-to-moderate Active Ulcerative Colitis - Salix Receives FDA Complete Response Letter For Balsalazide Tablet
Mild-to-moderate Active Ulcerative Colitis - Salix Receives FDA Complete Response Letter For Balsalazide Tablet
Mild-to-moderate Active Ulcerative Colitis - Salix Receives FDA Complete Response Letter For Balsalazide Tablet
Submitted by
admin
on January 3, 2009 - 11:44am
Source:
Medical News Today
News Tags:
Salix
ulcerative colitis
Balsalazide
Headline:
Mild-to-moderate Active Ulcerative Colitis - Salix Receives FDA Complete Response Letter For Balsalazide Tablet
Do Not Allow Advertisers to Use My Personal information
